Company Profile: Genzyme Corp. (NASDAQ:GENZ)
Автор: TradeTheTrend
Загружено: 2010-04-26
Просмотров: 589
Описание: The company's product portfolio focuses on rare genetic disorders as well as kidney disease, cancer, and biosurgery. One of its main products, Cerezyme, is a leading (and pricey) treatment for Gaucher disease, a rare enzyme-deficiency condition. Founded in 1981, Genzyme also is involved in drug development, genetic testing, and other services. In addition, the company develops gene-based cancer diagnosis and treatment products, renal care and immunological therapies, and orthopedic surgery products. Genzyme's products are sold to healthcare professionals in some 100 countries through a specialized marketing force and wholesale distributors.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
